Jury Brandolini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jury Brandolini has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Piergiorgio Solli
Thoracic Surgery Unit Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy
10 shared publications - Alessandro Pardolesi
Division of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
9 shared publications - Luca Bertolaccini
Department of Oncology and Hemato-oncology, University of Milan
7 shared publications - Alessia Stanzi
Division of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
2 shared publications - Clarissa Uslenghi
Division of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
2 shared publications - Giovanni Leuzzi
Division of Thoracic Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy
2 shared publications
Latest Publications
- Open Access
A Chronobiological Prognostic Model for Resected Stage I Non-Small-Cell Lung Cancer
Objectives: Chronobiology may influence outcomes in non-small-cell lung cancer (NSCLC), but its prognostic role in early-stage disease remains unclear. We evaluated the association between perioperative chronobiological variables, systemic inflammation, and long-term outcomes after complete resection for stage I NSCLC. Methods: 587 patients who underwent curative-intent resection for pathological stage I NSCLC between 2009 and 2018 were retrospectively reviewed. Chronobiological and inflammatory variables included season of surgery (spring/summer [21st March–22nd September], autumn/winter [23rd September–20th March]), time of day, day of week, and preoperative (CRP0 levels: low ≤ 3 mg/L, high > 3 mg/L) and postoperative day-3 (CRP3 levels: low ≤ 126 mg/L, high > 126 mg/L) C-reactive protein levels. The cohort was randomly divided into training (70%) and testing (30%) sets to develop and validate a prognostic model for overall survival (OS), taking into consideration the follow-up time. Disease-free survival (DFS) was analyzed as a secondary endpoint. Results: Median follow-up was 6.7 years, with 80 deaths and 108 recurrences recorded. In the training set, older age (p = 0.0049), stage IB disease (p = 0.0301), high CRP0 (p = 0.0049), and high CRP3 (p = 0.0280) were associated with worse OS, while surgery performed during autumn/winter was associated with improved OS (p = 0.0312). The multivariate Cox model including age, stage, and season of surgery showed the best prognostic performance (C-index 0.67, 95% Bonferroni-adjusted CI 0.50–0.83) and was internally validated in the testing cohort (C-index 0.69, 95%CI 0.52–0.86). The resulting linear predictor remained associated with both OS and DFS in the overall population. Conclusions: A simple model integrating age, pathological stage, and season of surgery was associated with long-term outcomes after surgery in stage I NSCLC. This model provides an exploratory framework integrating host-, tumor-, and chronobiological dimensions of prognosis. These findings require external validation and further investigation of the biological mechanisms underlying seasonal variation.
Open AccessA Chronobiological Prognostic Model for Resected Stage I Non-Small-Cell Lung Cancer
Objectives: Chronobiology may influence outcomes in non-small-cell lung cancer (NSCLC), but its prognostic role in early-stage disease remains unclear. We evaluated the association between perioperative chronobiological variables, systemic inflammation, and long-term outcomes after complete resection for stage I NSCLC. Methods: 587 patients who underwent curative-intent resection for pathological stage I NSCLC between 2009 and 2018 were retrospectively reviewed. Chronobiological and inflammatory variables included season of surgery (spring/summer [21st March–22nd September], autumn/winter [23rd September–20th March]), time of day, day of week, and preoperative (CRP0 levels: low ≤ 3 mg/L, high > 3 mg/L) and postoperative day-3 (CRP3 levels: low ≤ 126 mg/L, high > 126 mg/L) C-reactive protein levels. The cohort was randomly divided into training (70%) and testing (30%) sets to develop and validate a prognostic model for overall survival (OS), taking into consideration the follow-up time. Disease-free survival (DFS) was analyzed as a secondary endpoint. Results: Median follow-up was 6.7 years, with 80 deaths and 108 recurrences recorded. In the training set, older age (p = 0.0049), stage IB disease (p = 0.0301), high CRP0 (p = 0.0049), and high CRP3 (p = 0.0280) were associated with worse OS, while surgery performed during autumn/winter was associated with improved OS (p = 0.0312). The multivariate Cox model including age, stage, and season of surgery showed the best prognostic performance (C-index 0.67, 95% Bonferroni-adjusted CI 0.50–0.83) and was internally validated in the testing cohort (C-index 0.69, 95%CI 0.52–0.86). The resulting linear predictor remained associated with both OS and DFS in the overall population. Conclusions: A simple model integrating age, pathological stage, and season of surgery was associated with long-term outcomes after surgery in stage I NSCLC. This model provides an exploratory framework integrating host-, tumor-, and chronobiological dimensions of prognosis. These findings require external validation and further investigation of the biological mechanisms underlying seasonal variation.
- Open Access
Functional Recovery as a Survivorship Endpoint in Early-Stage NSCLC
Advances in screening, surgical techniques, perioperative care, and multimodality treatment have progressively expanded the population of long-term survivors with early-stage non-small cell lung cancer (NSCLC). However, disease-free survival does not necessarily correspond to complete functional recovery after curative-intent treatment. Many patients continue to experience persistent fatigue, dyspnea, reduced physical activity, impaired exercise tolerance, muscle loss, and deterioration in health-related quality of life despite adequate oncologic control. This narrative review discusses functional recovery as a survivorship endpoint in early-stage NSCLC, focusing on recovery trajectories, physiologic vulnerability, frailty, sarcopenia, rehabilitation, symptom burden, and emerging biologic frameworks such as allostatic load. Increasing evidence suggests that survivorship after NSCLC should not be interpreted exclusively according to recurrence or survival metrics, but also according to the ability to recover physiologic reserve, autonomy, and daily functioning after treatment. Functional recovery appears heterogeneous and influenced by multiple interacting factors, including baseline reserve, systemic inflammation, physical inactivity, behavioral adaptation, and cumulative stress burden. Rehabilitation strategies, structured symptom surveillance, and patient-reported outcomes may help identify vulnerable patients and improve long-term survivorship trajectories. Future survivorship models should probably integrate oncologic outcomes with longitudinal functional assessment to better characterize recovery patterns after treatment.
Open AccessFunctional Recovery as a Survivorship Endpoint in Early-Stage NSCLC
Advances in screening, surgical techniques, perioperative care, and multimodality treatment have progressively expanded the population of long-term survivors with early-stage non-small cell lung cancer (NSCLC). However, disease-free survival does not necessarily correspond to complete functional recovery after curative-intent treatment. Many patients continue to experience persistent fatigue, dyspnea, reduced physical activity, impaired exercise tolerance, muscle loss, and deterioration in health-related quality of life despite adequate oncologic control. This narrative review discusses functional recovery as a survivorship endpoint in early-stage NSCLC, focusing on recovery trajectories, physiologic vulnerability, frailty, sarcopenia, rehabilitation, symptom burden, and emerging biologic frameworks such as allostatic load. Increasing evidence suggests that survivorship after NSCLC should not be interpreted exclusively according to recurrence or survival metrics, but also according to the ability to recover physiologic reserve, autonomy, and daily functioning after treatment. Functional recovery appears heterogeneous and influenced by multiple interacting factors, including baseline reserve, systemic inflammation, physical inactivity, behavioral adaptation, and cumulative stress burden. Rehabilitation strategies, structured symptom surveillance, and patient-reported outcomes may help identify vulnerable patients and improve long-term survivorship trajectories. Future survivorship models should probably integrate oncologic outcomes with longitudinal functional assessment to better characterize recovery patterns after treatment.
- Open Access
- 21 January 2023
- Published by Elsevier in JTCVS Techniques
- Vol. 18, 168-170
Posttraumatic transmediastinal pulmonary hernia: An extremely rare clinical entity
- 21 January 2023
- Published by Elsevier in JTCVS Techniques
- Vol. 18, 168-170
Open AccessPosttraumatic transmediastinal pulmonary hernia: An extremely rare clinical entity
- Open Access
- 20 June 2022
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 93 (1)
Robotic resection of mediastinal left vagus neurofibroma
Neurogenic tumors represent 10 to 34% of all mediastinal tumors and among them, neurofibroma originating from the vagus nerve are rare entities. We present a case of a neurofibroma with cystic degeneration originating from the left branch of the vagus nerve in a 27-years-old man without von Recklinghausen disease. A complete robotic resection of the mediastinal mass has been performed, with amputation of the vagus nerve enclosed in the mass. The postoperative course was uneventful and the patient was discharged in two days.
- 20 June 2022
- Published by PAGEPress Publications in Monaldi Archives for Chest Disease
- Vol. 93 (1)
Open AccessRobotic resection of mediastinal left vagus neurofibroma
Neurogenic tumors represent 10 to 34% of all mediastinal tumors and among them, neurofibroma originating from the vagus nerve are rare entities. We present a case of a neurofibroma with cystic degeneration originating from the left branch of the vagus nerve in a 27-years-old man without von Recklinghausen disease. A complete robotic resection of the mediastinal mass has been performed, with amputation of the vagus nerve enclosed in the mass. The postoperative course was uneventful and the patient was discharged in two days.
- 1 May 2018
- Published by AME Publishing Company in ASVIDE
- Vol. 5, 517
Four arms robotic left upper lobectomy performed with da Vinci Xi System
- 1 May 2018
- Published by AME Publishing Company in ASVIDE
- Vol. 5, 517
Four arms robotic left upper lobectomy performed with da Vinci Xi System
- 1 April 2018
- Published by AME Publishing Company in ASVIDE
- Vol. 5, 389
Robotic left internal mammary lymph nodes dissection
- 1 April 2018
- Published by AME Publishing Company in ASVIDE
- Vol. 5, 389
Robotic left internal mammary lymph nodes dissection
- 1 November 2017
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 5 (21) , 423
Surgical treatment of synchronous multiple neuroendocrine lung tumours (case series): is more always better?
Pulmonary neuroendocrine lung tumours are uncommon neoplasm; the presence of multiple and synchronous lesions is rare, and few case report are described in the literature. We present a case series of three patients without particular symptom and radiologic finding of multiple synchronous pulmonary nodules. All the patients underwent surgical treatment; histopathologic examination revealed typical carcinoid tumours in all three cases (one patient has a synchronous atypical carcinoid). No oncological progressions were observed at follow-up. A review of current literature is also presented with a suggested strategy management.
- 1 November 2017
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 5 (21) , 423
Surgical treatment of synchronous multiple neuroendocrine lung tumours (case series): is more always better?
Pulmonary neuroendocrine lung tumours are uncommon neoplasm; the presence of multiple and synchronous lesions is rare, and few case report are described in the literature. We present a case series of three patients without particular symptom and radiologic finding of multiple synchronous pulmonary nodules. All the patients underwent surgical treatment; histopathologic examination revealed typical carcinoid tumours in all three cases (one patient has a synchronous atypical carcinoid). No oncological progressions were observed at follow-up. A review of current literature is also presented with a suggested strategy management.
- 1 October 2017
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 9 (10) , E907-E911
Chondroblastoma of the rib in a 47-year-old man: a case report with a systematic review of literature
Chondroblastoma is an uncommon benign bone tumour arising typically in the epiphysis. Few cases of chondroblastoma of the rib have been reported in the literature. We describe a case of chondroblastoma of a 47-year-old man located in the body of the IX right rib. The patient presented a moderate right thoracic pain with an apparently palpable mass. Computed tomography (CT) scan showed a well-defined oval 49 mm × 43 mm lesion with the lytic bone destruction of the rib. A surgical resection was performed with an excellent outcome and no recurrence after 4-year follow-up. We also conducted a systematic review of literature where we evidenced that chondroblastoma could affect people of all age, but it’s most common in children and young adult. Surgical resection constitutes the treatment of choice.
- 1 October 2017
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 9 (10) , E907-E911
Chondroblastoma of the rib in a 47-year-old man: a case report with a systematic review of literature
Chondroblastoma is an uncommon benign bone tumour arising typically in the epiphysis. Few cases of chondroblastoma of the rib have been reported in the literature. We describe a case of chondroblastoma of a 47-year-old man located in the body of the IX right rib. The patient presented a moderate right thoracic pain with an apparently palpable mass. Computed tomography (CT) scan showed a well-defined oval 49 mm × 43 mm lesion with the lytic bone destruction of the rib. A surgical resection was performed with an excellent outcome and no recurrence after 4-year follow-up. We also conducted a systematic review of literature where we evidenced that chondroblastoma could affect people of all age, but it’s most common in children and young adult. Surgical resection constitutes the treatment of choice.
- 1 September 2017
- Published by AME Publishing Company in ASVIDE
- Vol. 4 (1) , 422
Edited right upper lobectomy (robot daVinci Si)
- 1 September 2017
- Published by AME Publishing Company in ASVIDE
- Vol. 4 (1) , 422
Edited right upper lobectomy (robot daVinci Si)
- 1 June 2017
- Published by AME Publishing Company in ASVIDE
- Vol. 4 (1) , 258
Four arms robotic left lower lobectomy
- 1 June 2017
- Published by AME Publishing Company in ASVIDE
- Vol. 4 (1) , 258
Four arms robotic left lower lobectomy